(1)
Comparison of the Effectiveness and Safety of Allopurinol and Febuxostat Use in CKD Patients With Hyperuricemia: A Systematic Review. JFM 2026, 9 (1), 157-162. https://doi.org/10.35451/jfm.v9i1.3890.